Clinical Trials Directory

Trials / Completed

CompletedNCT02508974

Prevalence of Hospital Malnutrition in Adult Patients

Prevalence and Impact of Hospital Malnutrition on Associated Outcomes

Status
Completed
Phase
Study type
Observational
Enrollment
2,126 (actual)
Sponsor
University of Stellenbosch · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Malnutrition of patients on admission to hospitals are estimated to be as high as 60%, although the prevalence varies between countries. The impact of malnutrition on patient recovery and discharge is severe, with extensive cost implications. This study aims to assess the prevalence of at risk for malnutrition among adult patients admitted to hospital across 3 countries on the African continent.

Detailed description

The prevalence of malnutrition on admission to hospital varies between 15-60%. Knowing the extent of the problem and identifying at-risk patients should be a priority task since malnutrition is associated with increased hospital-related complications; longer length of stay, increased costs related to treatment and higher mortality. Post discharge, malnourished patients have also been linked to more frequent re-admissions, higher morbidity and mortality. Various screening tools are available, including the Nutrition Risk Screening-2002 recommended by European Society for Clinical Nutrition and Metabolism as the preferred screening tool for malnutrition in hospitals in Europe. ASPEN recommends a more comprehensive evaluation and diagnosis procedure. In South Africa, and the rest of Africa, nutritional screening is not routinely done and the investigators do not have any reliable national statistics indicating the extent of the problem. The aim of this study is to determine the prevalence of malnutrition on admission to hospital and to identify the impact thereof on relevant outcomes. Two different internationally recognised tools will be used and validated for the African context. In this multi-country, multi-centre descriptive cross-sectional study 3 hospitals in South Africa, 1 in Ghana and 2 in Kenya will be included. Adult patients (n=400 per hospital) will be screened on admission and at discharge and relevant outcomes (in-hospital and 3-month post-discharge) will be charted. A 50% sub-sample will be used to validate the 2 instruments.

Conditions

Timeline

Start date
2015-01-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2015-07-27
Last updated
2018-06-01

Locations

1 site across 1 country: South Africa

Source: ClinicalTrials.gov record NCT02508974. Inclusion in this directory is not an endorsement.